| 安云婷,乔志强,邹关燕,喻金梅.宫颈鳞癌患者卵巢移位后卵巢功能的动态监测分析[J].Chinese journal of Epidemiology,2014,35(1):85-87 |
| 宫颈鳞癌患者卵巢移位后卵巢功能的动态监测分析 |
| Dynamic monitoring on ovarian function among patients having had cervical squamous cell carcinoma transposition surgery |
| Received:September 08, 2013 |
| DOI： |
| KeyWord: 宫颈鳞癌 卵巢移位 卵巢功能 |
| English Key Word: Cervical carcinoma Ovarian transposition 0varian function |
| FundProject:江西省卫生厅科技计划(20081123) |
|
| Hits: 3309 |
| Download times: 1304 |
| Abstract: |
| 目的探讨宫颈鳞癌患者卵巢移位术后卵巢功能的变化及放射治疗(放疗)对移位卵巢内分泌功能的影响。方法对2009年1月至2012年6月在江西省妇幼保健院肿瘤科行卵巢移位的53例宫颈鳞癌患者进行回顾性分析。卵巢移位前全部患者激素水平均正常。纳入研究的患者国际妇产科联盟(FIGO)宫颈癌分期标准为I B1。ⅡB且均接受放疗，其中38例I B1.IIA2期患者因宫颈鳞癌根治术后存在危险因素补充放疗，15例ⅡB期患者为根治性同步放化疗前行卵巢移位。卵巢移位手术方法包括腹腔镜下卵巢移位和经腹卵巢移位。l 5例ⅡB期同步放化疗患者均为腹腔镜下卵巢移位；38例行宫颈癌根治术患者中31例为经腹卵巢移位，7例为腹腔镜卵巢移位。53例卵巢移位的患者均接受放疗。通过检测患者治疗前后血清雌二醇(E2)、促卵泡成熟素(FSH)、促黄体生成素(LH)水平监测卵巢内分泌功能。结果根据FIGO分期，I Bl期18例，I B2期15例，ⅡA1期3例，ⅡA2期2例，ⅡB期15例。患者年龄28～44岁，平均37.7岁，中位年龄38岁。22例腹腔镜卵巢移位手术放疗后卵巢功能正常14例(63.6％)，与放疗前(100.0％)的差异有统计学意义(P<0.05)。经腹卵巢移位手术放疗后卵巢功能正常22例(71.0％)，与放疗前(100.0％)的差异有统计学意义(P<0.05)。经腹卵巢移位术与腹腔镜两组患者放疗后卵巢功能正常比例的差异无统计学意义(P>0.05)。结论对于接受放疗的年轻宫颈鳞癌患者，即使行卵巢移位术，放疗后卵巢功能受损仍较明显，腹腔镜与经腹卵巢移位术对保护患者卵巢功能差异无统计学意义。 |
| English Abstract: |
| Objective To investigate the changes in ovarian function and the radiotheraputic influence on ovarian function on patients with cervical squamous cell carcinoma.Methotis We retrospectively analyzed 53 cases of cervical cancer patients FIGO staging I B1一lI B who had received ovarian transposition surgery at the Maternal and Child Health Hospital of Jiangxi province from January 2009 to June 20 l 2.An the patients included：in the study were FIIGO staging I B l—II B and had undergone radiation thlerapy.including 38 staging I B 1一ⅡA2 cervical cancer patients receiving chemo..therapy after radica]I radiotherapy due to the presence of risk factors and other 1 5 patients with stage II B to radical concurrent chemoradioth(erapy ovarian transposition.Ovarian transposition meth,ods would include laparoscopic ovarian transposition and transabdominal ovarian transposition.1 5 concurrent patients wiith stage lI B who currently receiving chemo-.radiotherapy were under laparoscopic ovarian transposition.Among the 38 radical hysterectomy patients，3 1 were having abdominal ovarian transposition.and the remaining 7 cases were laparoscopic.All the 53 patients had undergone radiotherapy.The levels of serum female hormones FSH，LH，E2 were determiIled to monitor the ovarian endocrine function.Results According to FI,GO staging.1 8 cases were stage I Bl。15 cases I B2，3 cases 1I A1.2 cases II A2 and 15 cases II B.Patients’age range was from 28 to 44 years old.with an average of 37.7 years.median age as 38 years.14 patients(63.6％)were still normalt ovarian function after radiotherapy by laparoscopic ovarian transposition.which was l 00.0％ before radiotherapy.There was a significant difference(P<0.05)compared with bel：fore radiotherapy.A,tier transabdominal ovarian transposition surgery and radiotherapy，normall ovarian function 22 cases (71.0％).and there was a significant difference(P<0.05)compared with be：fore radiotherapy.No significant difference was found with regard to the proportion of normal ovarian function after radiotherapy between the two groups of patients with 1aparoscopic and transabdominal ovarian transposition(P>0.05).Conclusion For the young cervical cancer patients，even with ovariantransposition，ovarian dysfunction was still evident after radiotherapy.There was no significant difference between laparoscopic and vansabdominal ovarian transposition. |
|
View Fulltext
Html FullText
View/Add Comment Download reader |
| Close |